Evidence map›Paper›PMID 30139991›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Noncardiac genetic predisposition in sudden infant death syndrome.

Belinda Gray, David J Tester, Leonie Ch Wong, Pritha Chanana, Amie Jaye, Jared M Evans, Alban-Elouen Baruteau, Margaret Evans, Peter Fleming, Iona Jeffrey and 5 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 6 countries.

Belinda GrayMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
David J TesterDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, Minnesota, USA.
Leonie Ch WongMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
Pritha ChananaDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Amie JayeMedical and Molecular Genetics, Guy's Hospital, King's College London, London, United Kingdom.
Jared M EvansDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Alban-Elouen BaruteauMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
Margaret EvansRoyal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Peter FlemingCentre for Child and Adolescent Health, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Iona JeffreyDepartment of Cellular Pathology, St George's University of London, London, United Kingdom.
Marta CohenHistopathology Department, Sheffield Children's Hospital NHS FT, Sheffield, United Kingdom.
Jacob Tfelt-HansenDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Michael A SimpsonMedical and Molecular Genetics, Guy's Hospital, King's College London, London, United Kingdom.
Michael J AckermanDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, Minnesota, USA. ackerman.michael@mayo.edu.
Elijah R BehrMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom. ebehr@sgul.ac.uk.
Department of Medical Sciences · BYKing's College Hospital · GBSt George’s University Hospitals NHS Foundation Trust · GBSt George's, University of London · GBCentenary Institute · AUCopenhagen University Hospital · DKEdinburgh Royal Infirmary · GBSheffield Children's Hospital · GBUniversity of Bristol · GB

Funding

Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)R01HD042569 · NICHD · MAYO CLINIC ROCHESTER · PI ACKERMAN, MICHAEL JOHN · 2002 to 2017
$6.9M
CONTROL OF HEMATOPOIESIS IN THE HUMAN FETAL LIVERK08HL001378 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI EMERSON, STEPHEN G · 1985 to 1985
–
British Heart Foundation FS/13/78/30520NICHD NIH HHS R01 HD042569
6 · The paper itself

Abstract

purposeSudden infant death syndrome (SIDS) is the commonest cause of sudden death of an infant; however, the genetic basis remains poorly understood. We aimed to identify noncardiac genes underpinning SIDS and determine their prevalence compared with ethnically matched controls.

methodsUsing exome sequencing we assessed the yield of ultrarare nonsynonymous variants (minor allele frequency [MAF] ≤0.00005, dominant model; MAF ≤0.01, recessive model) in 278 European SIDS cases (62% male; average age =2.7 ± 2 months) versus 973 European controls across 61 noncardiac SIDS-susceptibility genes. The variants were classified according to American College of Medical Genetics and Genomics criteria. Case-control, gene-collapsing analysis was performed in eight candidate biological pathways previously implicated in SIDS pathogenesis.

resultsOverall 43/278 SIDS cases harbored an ultrarare single-nucleotide variant compared with 114/973 controls (15.5 vs. 11.7%, p=0.10). Only 2/61 noncardiac genes were significantly overrepresented in cases compared with controls (ECE1, 3/278 [1%] vs. 1/973 [0.1%] p=0.036; SLC6A4, 2/278 [0.7%] vs. 1/973 [0.1%] p=0.049). There was no difference in yield of pathogenic or likely pathogenic variants between cases and controls (1/278 [0.36%] vs. 4/973 [0.41%]; p=1.0). Gene-collapsing analysis did not identify any specific biological pathways to be significantly associated with SIDS.

conclusionsA monogenic basis for SIDS amongst the previously implicated noncardiac genes and their encoded biological pathways is negligible.

Indexed as

AllelesAutopsyCase-Control StudiesEthnicityExomeExome SequencingFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic VariationHumansInfantInfant, NewbornMaleMutationSudden Infant Deathexome sequencingGeneticsmolecular autopsysudden infant death syndrome

Identifiers

PMID30139991
OpenAlexW2888438965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.